Relationship Between Oral Contraceptive Pills and Arthritis Risk
Study Overview
Researchers have meticulously explored the connection between oral contraceptive pills (OCPs) and the risk of developing arthritis, particularly rheumatoid arthritis (RA). A recent study published in the Annals of Rheumatic Diseases revealed that women who have used OCPs exhibited a significantly lower risk of developing ACPA-positive rheumatoid arthritis. This study particularly highlighted that women using OCPs for over seven years experienced a notable decrease in the risk of both ACPA-positive and ACPA-negative RA.
Significance of the Study
Given that rheumatoid arthritis is more common in women than in men, investigating the relationship between OCP usage and RA risk may indicate a potential hormonal influence. The findings stem from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA), one of the largest case-control studies involving women aged 18 and older who have been diagnosed with RA.
Methodology
Participants in the EIRA study completed a comprehensive questionnaire detailing their lifestyle choices and environmental factors, including OCP usage, breastfeeding practices, and other potential confounding factors such as alcohol consumption and smoking habits. The analysis included 2,578 RA cases and 4,129 controls, categorizing oral contraceptive users into several groups based on their usage patterns. “Current” users were defined as those actively taking OCPs for over a year, “past” users as those who ceased usage more than a year ago, “ever” users included both past and current users, while “never” users had never taken OCPs.
Findings
The analysis indicated that “ever” users of OCPs had a reduced risk of developing RA compared to non-users. Similar outcomes were observed among both current and past users of OCPs. A dose-response relationship was identified, indicating that women who used OCPs for more than seven years had a diminished risk of both ACPA-positive and ACPA-negative RA.
Secondary Outcomes
A secondary objective of the study examined the interaction between smoking status and OCP use concerning the risk of ACPA-positive RA. Smokers who did not use OCPs showed an odds ratio of 2.34, while those who used OCPs had an odds ratio of 1.71. This suggests a potential protective effect against ACPA-positive RA for women who smoke and use OCPs. However, since smoking and OCP use are associated with an increased risk of blood clots, it is possible that women who smoke may be less likely to be prescribed OCPs, complicating the analysis.
Conclusion
Rheumatoid arthritis is a multifaceted disease that remains partially understood. The higher prevalence in women suggests a hormonal component in its development. This study indicates that the use of oral contraceptive pills may reduce the risk of RA, especially when used for over seven years. As the largest study to date on this topic, it provides a more comprehensive analysis and will encourage further research into the biological mechanisms by which hormonal factors influence the development of RA.
Reference
Orellana C, Saevarsdottir S, Klareskog L, et al. Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis. 2017.